- Home
- AQST vs NHIC Comparison
AQST vs NHIC Comparison
Compare AQST & NHIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- NHIC
- Stock Information
- Founded
- AQST 2004
- NHIC 2024
- Country
- AQST United States
- NHIC United States
- Employees
- AQST N/A
- NHIC N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- NHIC
- Sector
- AQST Health Care
- NHIC
- Exchange
- AQST Nasdaq
- NHIC NYSE
- Market Cap
- AQST 254.1M
- NHIC 276.7M
- IPO Year
- AQST 2018
- NHIC 2025
- Fundamental
- Price
- AQST $2.79
- NHIC $10.02
- Analyst Decision
- AQST Strong Buy
- NHIC
- Analyst Count
- AQST 5
- NHIC 0
- Target Price
- AQST $11.40
- NHIC N/A
- AVG Volume (30 Days)
- AQST 939.1K
- NHIC 9.8K
- Earning Date
- AQST 05-12-2025
- NHIC 01-01-0001
- Dividend Yield
- AQST N/A
- NHIC N/A
- EPS Growth
- AQST N/A
- NHIC N/A
- EPS
- AQST N/A
- NHIC N/A
- Revenue
- AQST $57,561,000.00
- NHIC N/A
- Revenue This Year
- AQST N/A
- NHIC N/A
- Revenue Next Year
- AQST $39.51
- NHIC N/A
- P/E Ratio
- AQST N/A
- NHIC N/A
- Revenue Growth
- AQST 13.79
- NHIC N/A
- 52 Week Low
- AQST $2.20
- NHIC $10.26
- 52 Week High
- AQST $5.80
- NHIC $10.28
- Technical
- Relative Strength Index (RSI)
- AQST 49.93
- NHIC N/A
- Support Level
- AQST $2.59
- NHIC N/A
- Resistance Level
- AQST $3.05
- NHIC N/A
- Average True Range (ATR)
- AQST 0.16
- NHIC 0.00
- MACD
- AQST 0.00
- NHIC 0.00
- Stochastic Oscillator
- AQST 43.57
- NHIC 0.00
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About NHIC NEWHOLD INVESTMENT CORP III
NewHold Investment Corp III is a blank check company.